Silence of MEG3 intensifies lipopolysaccharide-stimulated damage of human lung cells through modulating miR-4262

References

• Altemeier WA, Chi FH, Matute-Bello G. Mouse models of acute lung injury. Berlin: Springer International Publishing; 2017.
   Google Scholar
• Jiang W, Luo F, Lu Q. The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state. Chem-Biol Interact. 2016;243:127.
   PubMed Web of Science ®Google Scholar
• Zhu GF, Guo HJ, Huang Y, et al. Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity. Exp Ther Med. 2015;10:2259.
   PubMed Web of Science ®Google Scholar
• Chen T, Mou Y, Tan J, et al. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2015;25:55–64.
   PubMed Web of Science ®Google Scholar
• Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016;40:480.
   PubMed Web of Science ®Google Scholar
• Al-Harbi NO, Imam F, Al-Harbi MM, et al. Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-κB, COX-2, and pro-inflammatory mediators. Immunol Investig. 2016;45:349.
   PubMed Web of Science ®Google Scholar
• Ogata-Suetsugu S, Yanagihara T, Hamada N, et al. Amphiregulin suppresses epithelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Biochem Biophys Res Commun. 2017;484:422–428.
   PubMed Web of Science ®Google Scholar
• Liu YL, Liu YJ, Liu Y, et al. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways. Int Immunopharmacol. 2014;23:649–657.
   PubMed Web of Science ®Google Scholar
• Wang R, Lu B, Gerard C, et al. C5L2, the second C5a anaphylatoxin receptor, suppresses LPS-induced acute lung injury. Am J Respir Cell Mol Biol. 2016;55:657.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Q, Deng Z, et al. Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of Hedgehog signaling pathway. Mol Biol Rep. 2011;38:3615–3622.
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–1789.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Yang FQ, Chen SJ, et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol. 2015;36:2947.
   PubMedGoogle Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cheng HP, Bao TP, et al. Expression of long non-coding RNA NANCI in lung tissues of neonatal mice with hyperoxia-induced lung injury and its regulatory effect on NKX2.1. Zhongguo Dang Dai er ke za Zhi = Chin J Contemp Pediatr. 2017;19:215–221.
   PubMedGoogle Scholar
• Shi X, Sun M, Liu H, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. 2015;54 (Suppl. 1):E1.
   PubMed Web of Science ®Google Scholar
• Guo W, Dong Z, Liu S, et al. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. Mol Carcinog. 2017;58:1924–1934.
   Web of Science ®Google Scholar
• Xia Y, He Z, Liu B, et al. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Mol Med Rep. 2015;12:4530.
   PubMed Web of Science ®Google Scholar
• Quesnel C, Nardelli L, Piednoir P, et al. Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance. Eur Respir J. 2010;35:1312–1321.
   PubMed Web of Science ®Google Scholar
• Villar J, Cabrera-Benitez NE, Ramos-Nuez A, et al. Early activation of pro-fibrotic WNT5A in sepsis-induced acute lung injury. Crit Care. 2014;18:568.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Dai J, Liao Y, et al. Sox9 protects against human lung fibroblast cell apoptosis induced by LPS through activation of the AKT/GSK3beta pathway. Biochem Moscow. 2017;82:606–612.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Ding XM, Pan L, Wang Y, et al. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice. Int J Mol Med. 2016;37:703.
   PubMed Web of Science ®Google Scholar
• Grailer JJ, Canning BA, Kalbitz M, et al. Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol. 2014;192:5974–5983.
   PubMed Web of Science ®Google Scholar
• Khandelwal A, Bacolla A, Vasquez KM, et al. Long non-coding RNA: a new paradigm for lung cancer. Mol Carcinog. 2015;54:1235.
   PubMed Web of Science ®Google Scholar
• Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
   PubMed Web of Science ®Google Scholar
• Terashima M, Tange S, Ishimura A, et al. MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial–mesenchymal transition in lung cancer cell lines. J Biol Chem. 2017;292:82.
   PubMed Web of Science ®Google Scholar
• He JH, Han ZP, Liu JM, et al. Overexpression of long non-coding RNA MEG3 inhibits proliferation of hepatocellular carcinoma Huh7 cells via negative modulation of miRNA-664. J Cell Biochem. 2017;118:3713–3721.
   PubMed Web of Science ®Google Scholar
• Golden RJ, Chen B, Li T, et al. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature. 2017;542:197–202.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li Z, Zhang Y, et al. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation. Oncol Rep. 2016;36:3657–3663.
   PubMed Web of Science ®Google Scholar
• Bao H, Gao F, Xie G, et al. Angiotensin-converting enzyme 2 inhibits apoptosis of pulmonary endothelial cells during acute lung injury through suppressing MiR-4262. Cell Physiol Biochem. 2015;37:759–767.
   PubMedGoogle Scholar
• Ghaleb AM, Yang VW. Krüppel-like factor 4 (KLF4): what we currently know. Gene. 2017;611:27–37.
   PubMed Web of Science ®Google Scholar
• Hu W, Jia Y, Yu Z, et al. KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth. Oncotarget. 2016;7:52870.
   PubMedGoogle Scholar
• Zhao J, Chao C, Guo M, et al. MicroRNA-7 deficiency ameliorates the pathologies of acute lung injury through elevating KLF4. Front Immunol. 2016;7:389.
   PubMed Web of Science ®Google Scholar
• Li C, Hu Y, Deng X, et al. Anti-apoptotic roles of MicroRNA-21 via activating PTEN/PI3K/Akt pathway in lipopolysaccharide-induced acute lung injury. Int J Clin Exp Pathol. 2017;10:4339–4347.
   Web of Science ®Google Scholar
• Wang D, Li CY, Jin T, et al. Regulation of ENaC-mediated alveolar fluid clearance by insulin via PI3K/Akt pathway in LPS-induced acute lung injury. Respir Res. 2012;13:29.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yu H, Liu Y, et al. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2016;311:L868.
   PubMed Web of Science ®Google Scholar
• Li C, Bo L, Li P, et al. Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in rat. Pulmon Pharmacol Ther. 2017;45:69–79.
   PubMed Web of Science ®Google Scholar